tetano
Editor, Senior Moderator
PLoS Pathog
. 2026 Nov 17;22(11):e1014799.
doi: 10.1371/journal.ppat.1014799. Online ahead of print.
Andrea Cottignies-Calamarte 1 2 , Alejandro De Cruz 1 2 , Cyril Planchais 3 , Françoise Porrot 2 , Daphné Rageot 1 2 3 , Irène Misguich 1 2 , Mateo Kryzpow 1 2 , Martin Jungbauer-Groznica 1 2 , Eva Thuillier 2 , Amelie Wileveau 2 , Isabelle Staropoli 2 , Florence Guivel-Benhassine 2 , Pierre Rosenbaum 4 , Ignacio Fernández 5 , Felix Rey 5 , Julian Buschrieser 2 , Sophie Trouillet-Assant 6 7 , Hugo Mouquet 4 , Olivier Schwartz 2 8 , Timothée Bruel 1 2 8
Affiliations Expand
The serine protease TMPRSS2 acts as a cofactor for SARS-CoV-2 entry by cleaving the viral spike (S) to initiate fusion. Whether TMPRSS2 has an impact on humoral immune response against S remains poorly characterized. Here, we show that TMPRSS2 impairs antibody binding to S. In S-expressing and infected cells, TMPRSS2 decreases monoclonal antibody (mAb) and immune serum binding, as well as antibody-dependent cellular cytotoxicity (ADCC) induction. Using a panel of 39 mAbs targeting various S regions, we observe that those binding to the S2 subunit are the most affected by TMPRSS2. TMPRSS2 promotes a partial shedding of S1 and changes S2 conformation. This processing reduces Angiotensin-Converting Enzyme 2 (ACE2) binding while increasing cell-cell fusion. We further observe that the capacity of TMPRSS2 to decrease antibody recognition is conserved across coronaviruses and shared with other TMPRSS proteins. However, TMPRSS2 expression in infected cells does not impact significantly virions' infectivity or the antibody recognition, as measured by flow virometry. Collectively, our findings suggest that TMPRSS2 processing of S favors a conformation which is less sensitive to antibody recognition.
. 2026 Nov 17;22(11):e1014799.
doi: 10.1371/journal.ppat.1014799. Online ahead of print.
TMPRSS2 reduces antibody recognition of SARS-CoV-2 spike
Andrea Cottignies-Calamarte 1 2 , Alejandro De Cruz 1 2 , Cyril Planchais 3 , Françoise Porrot 2 , Daphné Rageot 1 2 3 , Irène Misguich 1 2 , Mateo Kryzpow 1 2 , Martin Jungbauer-Groznica 1 2 , Eva Thuillier 2 , Amelie Wileveau 2 , Isabelle Staropoli 2 , Florence Guivel-Benhassine 2 , Pierre Rosenbaum 4 , Ignacio Fernández 5 , Felix Rey 5 , Julian Buschrieser 2 , Sophie Trouillet-Assant 6 7 , Hugo Mouquet 4 , Olivier Schwartz 2 8 , Timothée Bruel 1 2 8
Affiliations Expand
- PMID: 43043952
- DOI: 10.1371/journal.ppat.1014799
Abstract
The serine protease TMPRSS2 acts as a cofactor for SARS-CoV-2 entry by cleaving the viral spike (S) to initiate fusion. Whether TMPRSS2 has an impact on humoral immune response against S remains poorly characterized. Here, we show that TMPRSS2 impairs antibody binding to S. In S-expressing and infected cells, TMPRSS2 decreases monoclonal antibody (mAb) and immune serum binding, as well as antibody-dependent cellular cytotoxicity (ADCC) induction. Using a panel of 39 mAbs targeting various S regions, we observe that those binding to the S2 subunit are the most affected by TMPRSS2. TMPRSS2 promotes a partial shedding of S1 and changes S2 conformation. This processing reduces Angiotensin-Converting Enzyme 2 (ACE2) binding while increasing cell-cell fusion. We further observe that the capacity of TMPRSS2 to decrease antibody recognition is conserved across coronaviruses and shared with other TMPRSS proteins. However, TMPRSS2 expression in infected cells does not impact significantly virions' infectivity or the antibody recognition, as measured by flow virometry. Collectively, our findings suggest that TMPRSS2 processing of S favors a conformation which is less sensitive to antibody recognition.